Who makes Kogenate?
Bayer is committed to helping you start and stay on therapy regardless of changes in your commercial health insurance coverage status. Enroll now to gain access to this program! You may use this program to help fill insurance gaps for up to 4 months when: You experience changes in insurance for Kogenate.
How is Humate P made?
HUMATE-P is made from human blood and could contain infectious agents. The risk that these agents may transmit disease cannot be completely eliminated, but has been reduced by screening plasma donors and testing donated plasma for certain viruses, and by inactivating and/or removing viruses during manufacturing.
How is xyntha made?
XYNTHA is completely albumin-free †XYNTHA is manufactured using Chinese hamster ovary (CHO) cells from a master cell bank. These cells are grown in an albumin-free culture. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins.
Who makes recombinant?
The recombinant Antihemophilic Factor Concentrate (For Further Manufacturing Use), is produced by Baxter Healthcare Corporation and Wyeth BioPharma (For Further Manufacturing Use) and subsequently formulated and packaged at Baxter Healthcare Corporation.
What is the difference between Kogenate and Kovaltry?
The efficacy and the safety are what we’ve come to expect from Kogenate. Kovaltry is the same molecule so it has the same clinical efficacy and it’s indicated for all the same uses as Kogenate: for prophylaxis, for on-demand therapy and for surgery.
How is Kogenate given?
Routine Prophylaxis in Adults The recommended dose for routine prophylaxis is 25 units per kg of body weight three times per week. Kogenate FS is administered by intravenous injection after reconstitution. Patients should follow the specific reconstitution and administration procedures provided by their physicians.
https://www.youtube.com/watch?v=5uApMY4R-Q0